2132 related articles for article (PubMed ID: 18538731)
1. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
2. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
3. Targeting mitochondrial permeability in cancer drug development.
Berridge MV; Herst PM; Lawen A
Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
5. New targets for cancer chemotherapy.
Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
[No Abstract] [Full Text] [Related]
6. Mitochondria as therapeutic targets for cancer chemotherapy.
Galluzzi L; Larochette N; Zamzami N; Kroemer G
Oncogene; 2006 Aug; 25(34):4812-30. PubMed ID: 16892093
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy.
Pennington JD; Wang TJ; Nguyen P; Sun L; Bisht K; Smart D; Gius D
Drug Resist Updat; 2005 Oct; 8(5):322-30. PubMed ID: 16230045
[TBL] [Abstract][Full Text] [Related]
8. [Systemic and cellular pathways of anti-tumor action of plant adaptogenes].
Arushanian EB
Vopr Onkol; 2009; 55(1):15-23. PubMed ID: 19435193
[No Abstract] [Full Text] [Related]
9. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
Fujita N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase metabolism: roles in tumor progression and survival.
Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
[TBL] [Abstract][Full Text] [Related]
11. SPARC in cancer biology: its role in cancer progression and potential for therapy.
Tai IT; Tang MJ
Drug Resist Updat; 2008 Dec; 11(6):231-46. PubMed ID: 18849185
[TBL] [Abstract][Full Text] [Related]
12. Targeting TGFbeta-mediated processes in cancer.
Romano MF
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
14. Mitochondriotoxic compounds for cancer therapy.
Fantin VR; Leder P
Oncogene; 2006 Aug; 25(34):4787-97. PubMed ID: 16892091
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signal transduction pathway proteins as targets for cancer therapy.
Adjei AA; Hidalgo M
J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
[TBL] [Abstract][Full Text] [Related]
16. Overview of novel anticancer drug targets.
Buolamwini JK; Assefa H
Methods Mol Med; 2003; 85():3-28. PubMed ID: 12710193
[No Abstract] [Full Text] [Related]
17. Molecular biology. Cancer's perpetual source?
Marx J
Science; 2007 Aug; 317(5841):1029-31. PubMed ID: 17717165
[No Abstract] [Full Text] [Related]
18. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
Mousa SA; Petersen LJ
Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
[TBL] [Abstract][Full Text] [Related]
19. Cancer destruction in vivo through disrupted energy metabolism. Part III. Spontaneous drug resistance, selectivity of antineoplastic action, and strategies for intensifying tumor injury.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):195-212. PubMed ID: 1461933
[TBL] [Abstract][Full Text] [Related]
20. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]